Open Access

[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway

  • Authors:
    • Shuping You
    • Weihong Li
    • Yun Guan
  • View Affiliations

  • Published online on: February 19, 2024     https://doi.org/10.3892/mmr.2024.13184
  • Article Number: 60
  • Copyright : © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2024
Volume 29 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
You S, Li W and Guan Y: [Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway. Mol Med Rep 29: 60, 2024
APA
You, S., Li, W., & Guan, Y. (2024). [Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway. Molecular Medicine Reports, 29, 60. https://doi.org/10.3892/mmr.2024.13184
MLA
You, S., Li, W., Guan, Y."[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway". Molecular Medicine Reports 29.4 (2024): 60.
Chicago
You, S., Li, W., Guan, Y."[Retracted] Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK‑JNK‑mediated AKT/mTOR signaling pathway". Molecular Medicine Reports 29, no. 4 (2024): 60. https://doi.org/10.3892/mmr.2024.13184